FDA Drug recall D-0349-2019
Aprepitant Capsules, USP 40 mg, 1 capsule Unit Blister Pack, Rx Only, Manufactured in India for: Glenmark Pharmaceuticals Inc., USA Mahwah,…
- FDA Drug
- Class III
- terminated
- Published 2018-12-26
On 2018-12-26 the FDA classified a Class III recall of Aprepitant Capsules, USP 40 mg, 1 capsule Unit Blister Pack, Rx Only, Manufactured in India for: Glenmark Pharmaceuticals Inc., USA Mahwah,… by Glenmark Pharmaceuticals Usa, citing shortfill: Aprepitant capsules 40 mg is being recalled due to customer reports of missing capsule in the blister pack.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0349-2019 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2018-11-27 |
| Published | 2018-12-26 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Glenmark Pharmaceuticals Usa |
| Distribution | US |
Product
Aprepitant Capsules, USP 40 mg, 1 capsule Unit Blister Pack, Rx Only, Manufactured in India for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430. UPC 368462583401. NDC 68462-583-40
Reason
Shortfill: Aprepitant capsules 40 mg is being recalled due to customer reports of missing capsule in the blister pack.
Identifiers
| upc | 368462583401 |
|---|---|
| ndc | 68462-583-11 |
| ndc | 68462-583-85 |
| ndc | 68462-583-40 |
| ndc | 68462-584-58 |
| ndc | 68462-584-40 |
| ndc | 68462-584-76 |
| ndc | 68462-585-40 |
| ndc | 68462-585-76 |
| ndc | 68462-112-33 |
| ndc | 3684625834 |
| code_info | Lot: 17180918, EXP June 2020 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0349-2019%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.